Literature DB >> 20042885

The economic impact of a disability prevention program.

Bryan Dowd1, Michael McGrail, William H Lohman, Brent Sheasby, Heidi O'Connor, Marilou Calasanz, Robert Gorman, Stephen Parente.   

Abstract

We evaluated the effect of an employer- and clinic-based intervention on indemnity, medical, and workers compensation costs. The intervention was designed to improve communication and coordination of employer and physician efforts to help employees with work-related injuries to return-to-work. The research design was a quasi-experimental comparison of expenditures in treatment and control employers and clinics, controlling for differences in baseline expenditures and other characteristics of the subjects. We estimated that the employer and clinic interventions produced combined savings of $490 per employee per year (21% of total health expenditures). Ninety-four percent of savings came from reduced medical expenditure. Our findings suggest that relative modest efforts at coordinating appropriate medical care with employer accommodation that allow early reintegration of injured workers back into the workforce could result in substantial reductions of medical expenditures.

Mesh:

Year:  2010        PMID: 20042885     DOI: 10.1097/JOM.0b013e3181c5c358

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Financial implications of the continuity of primary care.

Authors:  Marcus J Hollander; Helena Kadlec
Journal:  Perm J       Date:  2014-11-24

2.  Return on Investment (ROI) and Development of a Workplace Disability Management Program in a Hospital-A Pilot Evaluation Study.

Authors:  Vincenzo Camisa; Francesco Gilardi; Eugenio Di Brino; Annapaola Santoro; Maria Rosaria Vinci; Serena Sannino; Natalia Bianchi; Valentina Mesolella; Nadia Macina; Michela Focarelli; Rita Brugaletta; Massimiliano Raponi; Livia Ferri; Americo Cicchetti; Nicola Magnavita; Salvatore Zaffina
Journal:  Int J Environ Res Public Health       Date:  2020-11-02       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.